Human CD34+ stem cells promote healing of diabetic foot ulcers in rats

Interactive Cardiovascular and Thoracic Surgery

Volumn 14, Issue 3, 2012, Pages 288-293

  Elsharawy, Mohamed A ^a   Naim, Magda ^a   Greish, Sahar ^b  

^a Suez Canal University Faculty of Medicine   (Egypt)

^b SUEZ CANAL UNIVERSITY   (Egypt)

Author keywords

Angiogenesis; CD34+ stem cells; Diabetic foot ulcers

Indexed keywords

COLLAGEN;

ANALYTICAL PARAMETERS; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD34+ STEM CELL; COLLAGEN METABOLISM; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DIABETIC FOOT; EPIDERMIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REVASCULARIZATION; STEM CELL; STREPTOZOCIN DIABETES; TRANSMISSION ELECTRON MICROSCOPY; ULCER HEALING; UMBILICAL CORD BLOOD; WOUND SIZE; WOUND SURFACE AREA;

ANIMALS; ANTIGENS, CD34; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC FOOT; EPIDERMIS; HUMANS; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; STEM CELL TRANSPLANTATION; STEM CELLS; WOUND HEALING;

EID: 84863437192     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivr068     Document Type: Article

References (25)

1. Boulton AJ, Meneses P, Ennis WJ. Diabetic foot ulcers: a framework for prevention and care. Wound Repair Regen 1999;7:7-16.
2. Ramsey S, Newton K, Blough D, McCulloch DK, Sandhu N, Reiber GE et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 1999;22:382-7.
3. Al-Wahbi AM. The diabetic foot in the Arab world. Saudi Med J 2006;27: 147-53.
4. Gu Y, Zhang J, Qi L. Comparative study on autologous implantation between bone marrow stem cells and peripheral blood stem cells for treatment of lower limb ischemia. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2007;21:675-8.
5. Kirana S, Stratmann B, Lammers D, Negrean M, Stirban A, Minartz P et al. Wound therapy with autologous bone marrow stem cells in diabetic patients with ischaemia-induced tissue ulcers affecting the lower limbs. Int J Clin Pract 2007;61:690-2.
6. Yang XF, Wu YX, Wang HM, Xu YF, Lü X, Zhang YB et al. Autologous peripheral blood stem cells transplantation in treatment of 62 cases of lower extremity ischemic disorder. Zhonghua Nei Ke Za Zhi 2005;44:95-8.
7. Sivan-Loukianova E, Awad OA, Stepanovic V, Bickenbach J, Schatteman GC. CD34+ blood cells accelerate neovascularization and healing of diabetic mouse skin wounds. J Vasc Res 2003;40:368-77.
8. Harris DT. Non-hematological uses of cord blood stem cells. Br J Hematol 2009;147:177-84.
9. Wagner JE. Umbilical cord blood stem cell transplantation. Cancer Treat Res 1995;76:195-213.
10. Miltenyi S, Müller W, Weichel W, Radbruch A. High gradient magnetic cell separation with MACS. Cytometry 1990;11:231-8.
11. Strober W. Trypan blue exclusion test of cell viability. Curr Protoc Immunol 2001; Appendix 3:Appendix 3B.
12. Harrington C, Zagari MJ, Corea J, Klitenic J. A cost analysis of diabetic lower-extremity ulcers. Diabetes Care 2000;23:1333-8.
13. Sivan-Loukianovaa OA, Awada V, Stepanovica J, Bickenbachb GC, Schattemana GC. CD34+ blood cells accelerate vascularization and healing of diabetic mouse skin wounds. J Vasc Res 2003;40:368-77.
14. Shi Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C, Ishida A et al. Evidence for circulating bone marrow derived endothelial cells. Blood 1998;92:362-7.
15. Procházka V, Gumulec J, Chmelová J, Klement P, Klement GL, Jonszta T et al. Autologous bone marrow stem cell transplantation in patients with end-stage chronical critical limb ischemia and diabetic foot. Vnitr Lek 2009;55:173-8.
16. Zhang M, Yu G. Research progress of stem cells transplantation for treating diabetic foot. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2009;23: 358-61.
17. Li J, Chen J, Kirsner R. Pathophysiology of acute wound healing. Clin Dermatol 2007;25:9-18.
18. Omar SM. Effect of chromium picolinate on histological skin alterations of streptozocin-diabetic rats. A light and electron microscopic study Egypt. J Histol 2010;33:178-91.
19. Loots MA, Lamme EN, Mekkes JR, Bos JD, Middelkoop E. Cultured fibroblasts from chronic diabetic wounds on the lower extremity (non-insulin-dependent diabetes mellitus) show disturbed proliferation. Arch Dermatol Res 1999;291:93-9.
20. Brem H, Stojadinovic O, Diegelmann RF, Entero H, Lee B, Pastar I et al. Molecular markers in patients with chronic wounds to guide surgical debridement. Mol Med 2007;13:30-9.
21. Martin A, Komada MR, Sane DC. Abnormal angiogenesis in diabetes mellitus. Med Res Rev 2003; 23:117-45.
22. Smiell JM, Wieman TJ, Steed DL, Perry BH, Sampson AR, Schwab BH. Efficacy and safety of Becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies. Wound Repair Regen 1999;7:335-46.
23. Schatteman GC, Hanlon HD, Jiao C, Dodds SG, Christy BA. Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J Clin Invest 2000;106:571-8.
24. Li S, Zhou B, Han ZC. Therapeutic neovascularization by transplantation of mobilized peripheral blood mononuclear cells for limb ischemia. A comparison between CD34+ and CD34- mononuclear cells. Thromb Haemost 2006;95:301-11.
25. Metcalfe AD, Ferguson MW. Tissue engineering of replacement skin: the crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration. J R Soc Interface 2007;4:413-37.